Showing 11-20 of 58 grants

Title Institution Researcher Program Duration Total Award Amount
Cellular Sentinels of Islet Transplant Rejection California Institute of Technology Mikhail Shapiro Cures 01-July-2023 to 30-June-2027 $750.000,00
Scalable GMP-Compliant Manufacturing of iPSC-Derived Insulin-Producing Cells: From Seed Train to Cryopreserved Product Cedars-Sinai Medical Center Dhruv Sareen Cures 01-April-2026 to 31-March-2028 $600.000,00
Engineering and Translational Control of Vascularization for Durable Islet Replacement Therapies Cedars-Sinai Medical Center Dhruv Sareen Cures 01-October-2026 to 30-September-2029 $899.998,80
IND Readiness Gap Analysis and Risk Assessment Dark Horse Consulting Amanda Mack Cures 15-June-2026 to 30-November-2026 $80.325,05
Broad Scope CMC, Non-Clinical, and Regulatory Support Dark Horse Consulting Nathan Manley Cures 01-September-2025 to 31-December-2026 $85.000,00
ENCRT-hPI (Immune-Protected ENCRT Extension Study), Evaluation of an immune-protected ENCRT-101 loaded with primary human islets in adults with Type 1 Diabetes, with and without standard-of-care portal vein islet infusion. Encellin Crystal Nyitray Cures 25-June-2026 to 24-June-2028 $2.500.000,00
Creation of a Commercializable Multi-Omics Resource from T1D Patient-Derived iPSC-Derived 3D Islet Organoid Models Greenstone Biosciences, Inc. Angelos Oikonomopoulos Cures 25-June-2026 to 24-June-2029 $1.200.000,00
Transcriptional memory in human islet organogenesis Lundquist Institute for Biomedical Medical Innovation at Harbor‐UCLA Medical Center (The Lundquist Institute) Eiji Yoshihara Cures 01-April-2022 to 31-March-2027 $749.995,50
Modeling immune-islet interactions in a vascularized T1D microphysiological system platform Regents of the University of California at Irvine Christopher Hughes Cures 01-October-2026 to 30-September-2027 $300.000,00
Building the Evidence to Address Disparities in Young children with Type 1 Diabetes: BEADY-T1D Stanford University Ananta Addala Improving Lives 01-February-2025 to 31-January-2029 $943.983,20